Open AccessAntagonists of Growth Hormone-Releasing Hormone and Vasoactive Intestinal Peptide Inhibit Tumor Proliferation by Different Mechanisms: Evidence from in Vitro Studies on Human Prostatic and Pancreatic Cancers
Author(s) -
Zoltán Rékási
Publication year - 2000
Publication title -
endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.674
H-Index - 257
eISSN - 1945-7170
pISSN - 0013-7227
DOI - 10.1210/en.141.6.2120
Subject(s) - lncap , vasoactive intestinal peptide , endocrinology , medicine , receptor , cell growth , growth hormone–releasing hormone , gastrointestinal hormone , biology , in vitro , secretion , somatostatin , pancreatic cancer , in vivo , peptide hormone , cancer cell , neuropeptide , hormone , cancer , growth hormone , biochemistry , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom